Cendakimab (Anti-IL-13)
Cendakimab (Anti-IL-13) (A2949-GRP)
Products
Description
Cendakimab (anti-IL-13) is a humanized, recombinant monoclonal antibody against the interleukin-13 (IL-13)Â molecule with the potential to treat allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis). MW: 146.44 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2949 |
| Target | Interleukins |